EVGN Evogene
- 1.6870
- +0.0670+4.14%
- 1.6000
- -0.0870-5.16%
About Evogene Company
Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. It operates through the following segments: Agriculture, Industrial Applications, and Human Health. The Agriculture segment develops seed traits, agrochemical products, and agro biological products to improve plant performance. The Industrial Applications focuses on the development and commercialization of improved castor bean seeds for industrial uses. The Human Health segment involves discovery and development of human microbiome-based therapeutics. The company was founded by Amir Barzilay and Hagai Karchi on October 10, 1999 and is headquartered in Rehovot, Israel.
Company Profile
Company Executives
- Name
- Position
- Salary
- Ofer Haviv
- President; Chief Executive Officer of Company and Canonic Ltd.
- 401.00K
- Amit Noam
- Chief Executive Officer; Lavie Bio Ltd
- --
- Dr. Elran Haber, PhD
- Chief Executive Officer; Biomica Ltd.
- 339.00K
- Yoash Zohar
- Chief Executive Officer; Casterra Ag Ltd.
- --
- Dr. Dan J. Gelvan, PhD
- Chief Executive Officer; Ag Plenus Ltd.
- --
- Yaron Eldad
- Chief Financial Officer
- --
- Dr. Nir Arbel
- Chief Product Officer
- 292.00K
- Mark Kapel
- Chief Technology Officer
- --
- Sassi Masliah
- Vice President, Corporate Development
- --
- Eyal Ronen
- Executive Vice President; Business Development
- --
- Sarit Firon
- Chairman of the Board
- --
- Professor Dr. Oded Shoseyov, PhD
- Independent Director
- --
- Nir Nimrodi
- Independent Director
- --
- Dan Falk
- Independent Director
- --
- Leon Y. Recanati
- Independent Director
- --
- Dr. Adrian Percy, B.Sc. ,M. Sc.,PhD
- Independent Director
- --
Analysis
Price Target
No Data
No Data